Ketamine is an anesthetic medication that is now used for treating depression and other conditions. We provide ketamine infusion services for depression which has not responded to other treatments. Although not currently FDA approved for the treatment of depression, intravenous ketamine treatment of depression is supported by over a decade of scientific research. Working through a different mechanism than typical antidepressants, ketamine provides far more rapid results than traditional treatments. Not everyone responds to ketamine, but many patients report improvement within hours to days of beginning treatment.
An evaluation in the office is required before approval for ketamine treatment, even if you have received ketamine treatments somewhere else in the past.
Esketamine (Spravato™) is FDA-approved for treatment-resistant depression. It is chemically related to ketamine, which is also used for depression. Given intranasally, esketamine must be administered and monitored in an approved clinic, and will require 2 hours of observation in the clinic following each administration.
The course of treatment is twice a week for 4 weeks, then weekly to every other week indefinitely.
An evaluation in the office is required before approval for ketamine or esketamine treatment, even if you have received ketamine treatments somewhere else in the past. Treatment is coordinated by Lott Behavioral Health, which is approved for giving esketamine (Spravato™) treatments, as listed in the treatment locator.